Trial intelligence / Profile preview

SYNTHESIS: Intra-arterial versus intravenous alteplase in acute ischemic stroke

2007-004512-32Phase 3Completed

Sponsor
ASST Grande Ospedale Metropolitano Niguarda
Start
Oct 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoint: Survival free of disability. Started Oct 2007; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on 2007-004512-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004512-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call